TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30851050

Group type: EXPERIMENTAL
Intervention: Toothpaste with anti-adhesive zinc-substituted carbonated hydroxyapatite (HA)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Toothpaste with antimicrobial and anti-adhesive amine fluoride/stannous fluoride (AmF/SnF2)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both toothpaste formulations
Number of subjects: 41
Study: 29023536

Group type: EXPERIMENTAL
Intervention: Physical training and nutritional support (PTN)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Social support (SoSu)
Number of subjects: 58
Study: 26285327

Group type: EXPERIMENTAL
Intervention: Intravenous laser irradiation of the blood in addition to traditional medicamental treatment (n = 102)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Traditional medicamental treatment alone (Control group, n = 30)
Number of subjects: 132
Study: 23579324

Group type: EXPERIMENTAL
Intervention: omalizumab
Number of subjects: 41

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 41
Study: 21034232

Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope with chest compressions
Number of subjects: 20

Group type: COMPARATOR
Intervention: Macintosh laryngoscope without chest compressions
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: GlideScope Ranger with chest compressions
Number of subjects: 20

Group type: COMPARATOR
Intervention: GlideScope Ranger without chest compressions
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Airway Scope with chest compressions
Number of subjects: 20

Group type: COMPARATOR
Intervention: Airway Scope without chest compressions
Number of subjects: 20
Study: 19179870

Group type: EXPERIMENTAL
Intervention: Extracorporeal Membrane Oxygenation (ECMO) for Severe Adult Respiratory Failure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interventional lung assist (pumpless arteriovenous extracorporeal technique)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microfiber, microporous polymethylpentene membrane lungs
Number of subjects: 0
Study: 17355745

Group type: EXPERIMENTAL
Intervention: rosuvastatin 40 mg
Number of subjects: 984

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 984
Study: 15100337

Group type: EXPERIMENTAL
Intervention: Guideline implementation intervention including a tutorial for intake clinicians, group and individual performance feedback, use of a modified vital signs stamp, offer of free nicotine replacement therapy, and proactive telephone counseling.
Number of subjects: 2163

Group type: COMPARATOR
Intervention: Control group receiving only general information about the AHRQ Guideline.
Number of subjects: 2163
Study: 11465656

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 12
Study: 9779342

Group type: EXPERIMENTAL
Intervention: GM‐CSF prophylaxis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: G‐CSF
Number of subjects: 0
Study: 9364699

Group type: EXPERIMENTAL
Intervention: Virosome-formulated influenza vaccine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Subunit influenza vaccine
Number of subjects: 100
Study: 2388129

Group type: EXPERIMENTAL
Intervention: VK1 (20 mg orally)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: VK2 (20 mg orally)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: VK1 and VK2 (20 mg orally)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control
Number of subjects: 33
Study: 6790990

Group type: EXPERIMENTAL
Intervention: Activated prothrombin-complex concentrate (FEIBA)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control preparation (nonactivated prothrombin-complex concentrate)
Number of subjects: 15
Study: 31116187

Group type: EXPERIMENTAL
Intervention: 5 × 5 mm dental implants with a nanostructured calcium‐incorporated titanium surface
Number of subjects: 80

Group type: COMPARATOR
Intervention: 10-mm or longer implants in augmented bone
Number of subjects: 80

Group type: COMPARATOR
Intervention: Short implants in mandibles
Number of subjects: 80

Group type: COMPARATOR
Intervention: Short implants in maxillae
Number of subjects: 80
Study: 28597177

Group type: EXPERIMENTAL
Intervention: Family Foundations program (intervention)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study: 26077040

Group type: EXPERIMENTAL
Intervention: Nasal packing
Number of subjects: 74

Group type: COMPARATOR
Intervention: Unpacked side (control)
Number of subjects: 74
Study: 24964105

Group type: EXPERIMENTAL
Intervention: GAL/NIM
Number of subjects: 21

Group type: COMPARATOR
Intervention: GAL/PLA
Number of subjects: 21
Study: 22198635

Group type: EXPERIMENTAL
Intervention: Combination of 1-mg reproterol and 2-mg disodium cromoglycate (DSCG)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Short-acting β-agonist reproterol alone
Number of subjects: 11

Group type: COMPARATOR
Intervention: Disodium cromoglycate (DSCG) alone
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 18449549

Group type: EXPERIMENTAL
Intervention: 400 microg of misoprostol vaginally (self administered) 4‐6 h prior to hysteroscopy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no cervical priming)
Number of subjects: 100
Study: 17697036

Group type: EXPERIMENTAL
Intervention: 1 g paracetamol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 1 g paracetamol plus 30 mg dextromethorphan
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 15370724

Group type: EXPERIMENTAL
Intervention: 5 mg tropisetron daily intravenous bolus injection for 5 days
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 11407105

Group type: EXPERIMENTAL
Intervention: Angiotensin receptor blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aldosterone antagonists
Number of subjects: 0
Study: 9362821

Group type: EXPERIMENTAL
Intervention: Competency‐based, written self‐learning module
Number of subjects: 67

Group type: COMPARATOR
Intervention: Competency‐based, didactic lecture module
Number of subjects: 67
Study: 1482431

Group type: EXPERIMENTAL
Intervention: Preincisional lidocaine infiltration (1% lidocaine, 40 mL)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Postincisional lidocaine infiltration (1% lidocaine, 40 mL)
Number of subjects: 37
Study: 2861315

Group type: EXPERIMENTAL
Intervention: Naloxone (0.4 to 1.2 mg intravenously)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (vehicle for injection)
Number of subjects: 23
Study: 31404499

Group type: EXPERIMENTAL
Intervention: Targeted lung denervation (TLD)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Sham bronchoscopy
Number of subjects: 82
Study: 30404626

Group type: EXPERIMENTAL
Intervention: Dasatinib (SRC inhibitor)
Number of subjects: 0
Study: 27575492

Group type: EXPERIMENTAL
Intervention: Video and simulator
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Video only
Number of subjects: 133

Group type: COMPARATOR
Intervention: Self-study only
Number of subjects: 133
Study: 24811331

Group type: EXPERIMENTAL
Intervention: Acetazolamide (2 × 250 mg/d)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 22380745

Group type: EXPERIMENTAL
Intervention: Pressure Support Ventilation (PSV)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Spontaneous Ventilation (SV)
Number of subjects: 24
Study: 20095796

Group type: EXPERIMENTAL
Intervention: Lapatinib plus paclitaxel (L + P)
Number of subjects: 579

Group type: COMPARATOR
Intervention: Paclitaxel plus placebo (P + pla)
Number of subjects: 579
Study: 18094551

Group type: EXPERIMENTAL
Intervention: ThinPrep test with voided urine (V)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ThinPrep test with drained urine (D)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ThinPrep test with irrigated urine (I)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MAGE test with voided urine (V)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MAGE test with drained urine (D)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MAGE test with irrigated urine (I)
Number of subjects: 30
Study: 16134739

Group type: EXPERIMENTAL
Intervention: Cognitive training programme for 30 minutes per day for 17 weeks
Number of subjects: 38

Group type: COMPARATOR
Intervention: Freely chosen interactive activity for 30 minutes per day for 17 weeks
Number of subjects: 38
Study: 11846194

Group type: EXPERIMENTAL
Intervention: Single strip application with root planing
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Multiple strip application with root planing
Number of subjects: 24

Group type: COMPARATOR
Intervention: Root planing alone
Number of subjects: 24

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 24
Study: 10628577

Group type: EXPERIMENTAL
Intervention: Scenario A (insomnia and poor concentration meeting DSM-III-R criteria for major depressive disorder)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Scenario B (tension headaches meeting criteria for minor depression)
Number of subjects: 149
Study: 7536830

Group type: EXPERIMENTAL
Intervention: High-protein, high-energy drink
Number of subjects: 4

Group type: COMPARATOR
Intervention: No-protein, low-energy drink
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Follow-up study
Number of subjects: 4
Study: 12041767

Group type: EXPERIMENTAL
Intervention: Imipenem/cilastatin (2 or 4 g/day)
Number of subjects: 22
Study: 6348425

Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cefamandole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both groups (Cefazolin and Cefamandole)
Number of subjects: 0
Study: 31662372

Group type: EXPERIMENTAL
Intervention: General health checks offered to invitees with follow-up consultations if test results were abnormal.
Number of subjects: 3464

Group type: COMPARATOR
Intervention: General health checks offered to invitees compared to the external control group (remaining Danish population receiving routine care).
Number of subjects: 3464
Study: 30422263

Group type: EXPERIMENTAL
Intervention: Integrated electronic clinical decision support system (CDSS) implemented at intervention sites.
Number of subjects: 1703

Group type: COMPARATOR
Intervention: Control group (no CDSS intervention).
Number of subjects: 1703
Study: 27549145

Group type: EXPERIMENTAL
Intervention: Tailored return to work (RTW) program
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 171
Study: 24126967

Group type: EXPERIMENTAL
Intervention: Pedometer-based individual counseling (PedIC)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Pedometer-based group counseling (PedGC)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Minimal treatment comparator (MTC)
Number of subjects: 195
Study: 21942235

Group type: EXPERIMENTAL
Intervention: Adper Scotchbond Multi‐Purpose (MP, 3M ESPE)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Adper Single Bond Plus (SB, 3M ESPE)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Adper Scotchbond SE (SE, 3M ESPE)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Adper Easy Bond (EB, 3M ESPE)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: All adhesives
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Self-etch adhesives (EB and SE)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Adper Easy Bond (EB)
Number of subjects: 39
Study: 21130362

Group type: EXPERIMENTAL
Intervention: Biofeedback therapy (3 weeks duration)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 36
Study: 17555385

Group type: EXPERIMENTAL
Intervention: Reduced urinary sodium
Number of subjects: 782

Group type: EXPERIMENTAL
Intervention: Improved fitness
Number of subjects: 782

Group type: EXPERIMENTAL
Intervention: Adherence to the DASH diet
Number of subjects: 782

Group type: EXPERIMENTAL
Intervention: Fitness change (with weight included)
Number of subjects: 782
Study: 16378069

Group type: EXPERIMENTAL
Intervention: Tac/MMF
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Bas/Tac
Number of subjects: 451

Group type: COMPARATOR
Intervention: Triple therapy
Number of subjects: 451
Study: 11896838

Group type: EXPERIMENTAL
Intervention: Tactile (probe) and cold air (dental air syringe) stimuli used for clinical evaluation of DH.
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Tactile stimulation
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Thermal stimulation
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Both tactile and thermal stimulation
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Teeth responding to stimuli
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Comparison of tactile and thermal/evaporative stimulation
Number of subjects: 117
Study: 9648697

Group type: EXPERIMENTAL
Intervention: Bla g 1 (cockroach allergen)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bla g 2 (cockroach allergen)
Number of subjects: 40
Study: 8005909

Group type: EXPERIMENTAL
Intervention: Modified quiet room (QR) with tea rose walls, carpeted floor, and mural
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard quiet room (QR)
Number of subjects: 19
Study: 2460291

Group type: EXPERIMENTAL
Intervention: Oxybuprocaine (OBu)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Tetracaine (Tetra)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CH)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Benzalkonium chloride (BAK)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Oxybuprocaine (OBu) + Chlorhexidine (CH)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Oxybuprocaine (OBu) + Benzalkonium chloride (BAK)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Tetracaine (Tetra) + Benzalkonium chloride (BAK)
Number of subjects: 2
Study: 31564452

Group type: EXPERIMENTAL
Intervention: Knowledge about vaccines recommended for HCWs
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Knowledge about hepatitis B and influenza vaccines
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Self-reported immunization coverage for hepatitis B
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Self-reported immunization coverage for tetanus and pertussis
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Self-reported immunization coverage for measles/mumps/rubella
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Self-reported immunization coverage for chickenpox
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Self-reported immunization coverage for influenza
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Prior receipt of all recommended vaccines
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Self-reported immunization likelihood based on age and knowledge
Number of subjects: 531
Study: 27634224

Group type: EXPERIMENTAL
Intervention: 25% calorie restricted diet (CR) for 6 months
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard diet (SD) for 6 months
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 25% calorie restricted diet (CR)
Number of subjects: 70
Study: 26299380

Group type: EXPERIMENTAL
Intervention: Nurse-led lifestyle counselling sessions
Number of subjects: 71
Study: 22860316

Group type: EXPERIMENTAL
Intervention: Mailed intervention containing a letter from attending physician, a postcard for decision aid request, and information on obtaining screening.
Number of subjects: 1598

Group type: COMPARATOR
Intervention: Control group (resident physicians' patients in wave B).
Number of subjects: 1598

Group type: COMPARATOR
Intervention: Control group (requests for decision aids).
Number of subjects: 1598
Study: 20059570

Group type: EXPERIMENTAL
Intervention: Yoga lifestyle intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard of care treatment
Number of subjects: 60
Study: 18324410

Group type: EXPERIMENTAL
Intervention: Glycerol and icthammol (G&I) ribbon gauze
Number of subjects: 43

Group type: COMPARATOR
Intervention: Topical antibiotic and steroid drops
Number of subjects: 43
Study: 15954181

Group type: EXPERIMENTAL
Intervention: Automatic repositioning method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Eye method (control)
Number of subjects: 0
Study: 11821506

Group type: EXPERIMENTAL
Intervention: Daily hemodialysis
Number of subjects: 160

Group type: COMPARATOR
Intervention: Conventional (alternate-day) hemodialysis
Number of subjects: 160
Study: 10406358

Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8793123

Group type: EXPERIMENTAL
Intervention: EEG mapping with band powers and coherence analysis
Number of subjects: 0
Study: 1703746

Group type: EXPERIMENTAL
Intervention: Ampicillin-chloramphenicol combination
Number of subjects: 49

Group type: COMPARATOR
Intervention: Chloramphenicol alone
Number of subjects: 49
Study: 6968705

Group type: EXPERIMENTAL
Intervention: 4-lumen tube incorporating an extra lumen for oesophageal suction
Number of subjects: 28

Group type: COMPARATOR
Intervention: modified 3-lumen Sengstaken tube
Number of subjects: 28
Study: 31581690

Group type: EXPERIMENTAL
Intervention: Sauna yoga at moderate temperature (50 °C)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 23
Study: 29292040

Group type: EXPERIMENTAL
Intervention: Mental imagery cognitive training
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Flashcards cognitive training
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (simulation training only)
Number of subjects: 59
Study: 27983900

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (group 1, n=20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Microdebrider reduction (group 2, n=20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 40
Study: 25329201

Group type: EXPERIMENTAL
Intervention: GERA (Genetic and Environmental Risk Assessment)
Number of subjects: 783

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 783

Group type: EXPERIMENTAL
Intervention: GERA (within GERA group)
Number of subjects: 783

Group type: EXPERIMENTAL
Intervention: Elevated-risk participants (within GERA group)
Number of subjects: 783

Group type: EXPERIMENTAL
Intervention: GERA
Number of subjects: 783
Study: 23155345

Group type: EXPERIMENTAL
Intervention: Activated carbon nanoparticles suspension (ACNS), 1 mL subserosal injection in a 4-quadrant region around the mass.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Methylene blue (MB), 2 mL injected into the isolated, stretched and fixed vessel after specimen removal.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (non-stained conventional surgical group), no ACNS or MB injected.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 60
Study: 20036361

Group type: EXPERIMENTAL
Intervention: Birth plan intervention
Number of subjects: 296

Group type: COMPARATOR
Intervention: Control group (no birth plan)
Number of subjects: 296
Study: 18580400

Group type: EXPERIMENTAL
Intervention: Salbutamol 200 microg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Salbutamol 800 microg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 16483177

Group type: EXPERIMENTAL
Intervention: 0.125 mg ganirelix sc daily for 7 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.250 mg ganirelix sc daily for 7 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.500 mg ganirelix sc daily for 7 days
Number of subjects: 24
Study: 11940273

Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gastric tonometry
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enteral nutrition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extracorporeal membrane oxygenation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Closed intensive care units
Number of subjects: 0
Study: 10601934

Group type: EXPERIMENTAL
Intervention: Daily nonstress test
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Daily biophysical profile
Number of subjects: 135
Study: 8848515

Group type: EXPERIMENTAL
Intervention: Scopolamine (muscarinic antagonist)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mecamylamine (nicotinic antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 0
Study: 2286929

Group type: EXPERIMENTAL
Intervention: Selective elimination of oral flora
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: COMPARATOR
Intervention: Chlorhexidine rinsing
Number of subjects: 15
Study: 7021067

Group type: EXPERIMENTAL
Intervention: racemic epinephrine (RE) nebulized and delivered by manual IPPB
Number of subjects: 14

Group type: COMPARATOR
Intervention: distilled water nebulized and delivered by manual IPPB
Number of subjects: 14
Study: 31284490

Group type: EXPERIMENTAL
Intervention: 60 mg/day anthocyanins (Group A)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 6 mg lutein and 2 mg zeaxanthin per day (Group X)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Combination of anthocyanins and xanthophylls (Group A+X)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: All three groups (A, X, A+X)
Number of subjects: 72
Study: 25884343

Group type: EXPERIMENTAL
Intervention: Vertebroplasty
Number of subjects: 100

Group type: COMPARATOR
Intervention: Kyphoplasty
Number of subjects: 100
Study: 24389883

Group type: EXPERIMENTAL
Intervention: Lateral decubitus, knee-chest position with a 45-degree head-up tilt (group M, n = 100)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Sitting position (group S, n = 100)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Lateral decubitus, knee-chest position (group L, n = 100)
Number of subjects: 300
Study: 22678961

Group type: EXPERIMENTAL
Intervention: Intense, resistance exercise training (12-week periodized, intensive resistance training)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intense, resistance exercise training
Number of subjects: 40
Study: 19573972

Group type: EXPERIMENTAL
Intervention: Dual Operator CPR
Number of subjects: 50

Group type: COMPARATOR
Intervention: Single Operator CPR
Number of subjects: 50
Study: 17855762

Group type: EXPERIMENTAL
Intervention: E45 (90 min of exercise at 45% V(O2)peak)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: E65 (60 min of exercise at 65% V(O2)peak)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: E45
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: E45 and E65
Number of subjects: 18

Group type: COMPARATOR
Intervention: C (sedentary control trial)
Number of subjects: 18
Study: 16164885

Group type: EXPERIMENTAL
Intervention: Low-fat, vegan diet
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control diet (National Cholesterol Education Program guidelines)
Number of subjects: 64